The Global Artificial Intelligence Revolution Challenges Patent Eligibility Laws

This Article examines patent eligibility jurisprudence of artificial intelligence in the United States, Europe, France, Japan, and Singapore. It identifies de facto requirements of patent-eligible artificial intelligence. It also examines the adaptability of patent eligibility jurisprudence to adapt with the growth of artificial intelligence

Thirty years of artificial intelligence in medicine (AIME) conferences: A review of research themes

Over the past 30 years, the international conference on Artificial Intelligence in MEdicine (AIME) has been organized at different venues across Europe every 2 years, establishing a forum for scientific exchange and creating an active research community. The Artificial Intelligence in Medicine journal has published theme issues with extended versions of selected AIME papers since 1998

Social impact of artificial intelligence in Europe

La Inteligencia Artificial (IA) puede ser una herramienta de gran ayuda para el crecimiento y desarrollo de la sociedad. Para conseguir un enfoque más cercano y una evolución más eficaz de esta tecnología, la Comision Europea ha creado la red AI DIH, la cual centra su visión en el soporte de las pymes y sector público para implementar la IA en las diferentes regiones de Europa, ayudando a reducir la brecha entre las grandes corporaciones especializadas. En este documento se contextualiza la funcionalidad de la red DIH y cómo está actuando de cara a la IA, para introducir el análisis de los diferentes centros colaborativos enfocados a la IA. El resultado es una propuesta de técnicas, modelos y parámetros que pueden implementarse en esta red de centros, con el apoyo de Living Labs, para incrementar la efectividad y mejorar el producto/servicio final.Artificial intelligence (AI) can be a very useful tool for the growth and development of society. To achieve a closer approach and a more effective evolution of this technology, the European Commission has created the AI DIH network, which focuses its vision on supporting SMEs and the public sector to implement AI in the different regions of Europe, helping to close the gap between large specialized corporations. This document contextualizes the functionality of the DIH network and how it is acting in the face of AI, to introduce the analysis of the different collaborative centers focused on AI. The result is a proposal of techniques, models and parameters that can be implemented in this network of centers, supported by Living Labs, to increase effectiveness and improve the final product/service

NEUROTECH - A European Community of Experts on Neuromorphic Technologies

Neuromorphic Computing Technology (NCT) is becoming a reality in Europe thanks to a coordinated effort to unite the EU researchers and stakeholders interested in neuroscience, artificial intelligence, and nanoscale technologies

Artificial Intelligence in Medicine

If one posed a question on how ready is the Republic of Croatia, for use of artificial intelligence in legal and legislative terms in medicine, the answer at this point would be – it is not. The fact is that processes in medicine involve the application of state-of-the-art technologies, as is artificial intelligence, but it is also a controversial fact that the health legislative system does not develop seemingly, in the direction in which it is assumed, according to standards that exist in other developed countries of Europe and the world. Our society awaits many challenges due to the use of ever more ubiquitous applications of artificial intelligence and state-of-the-art, sophisticated technologies and technological processes in treatment, which will need regulation through the prescribed cognitive legal norm. Regulation of the medical treatment process driven by artificial intelligence, must be in place through the norm because the area is too important to be left to technological progress without legal control and adequate legal regulation. In this regard, medicine and all treatment processes, diagnostics and therapies in the health care system must be carried out with one single clear goal, which is the protection and preservation of human health and life

The Future of Artificial Intelligence in the Healthcare Industry

Technology has played an immense role in the evolution of healthcare delivery for the United States and on an international scale. Today, perhaps no innovation offers more potential than artificial intelligence. Utilizing machine intelligence as opposed to human intelligence for the purposes of planning, offering solutions, and providing insights, AI has the ability to alter traditional dynamics between doctors, patients, and administrators; this reality is now producing both elation at artificial intelligence\u27s medical promise and uncertainty regarding its capacity in current systems. Nevertheless, current trends reveal that interest in AI among healthcare stakeholders is continuously increasing, and with the current COVID-19 pandemic highlighting institutional flaws, it is reasonable to assume that many industry changes proposed by artificial intelligence will be further considered in the coming years. Therefore, this research aims to assess the changes proposed by AI and how they might impact relations between doctors, patients, administrators, and other relevant parties. It ultimately finds that the U.S. cannot certify artificial intelligence as its definitive future for healthcare, nor should it overlook other viable options to better health services, so long as a firm definition of AI is not clarified and the understructure of the American healthcare system - mainly represented through electronic health records - lingers behind those achieved in Europe and Asia. The research culminates in recommendations for addressing barriers to achieving healthcare AI so that, if AI tools can one day integrate into medical practices, an optimal relationship may flourish between technology and healthcare